Search clinical trials for: BAFF-R CAR-T

Total 1414 results

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Recruiting

Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma

B-cell Lymphoma

China
Institute of Hematology & Blood Diseases Hospital...
Hebei Taihe Chunyu Biotechnology Co., Ltd

Recruiting

Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma

DLBCL | CLL | MCL | MZL | FL | WM

China
Qi deng

Not yet recruiting

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

Lymphoma | Acute Leukemia | CAR T Cell Therapy
Zhejiang University
Shanghai YaKe Biotechnology Ltd.

Recruiting

CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases

Autoimmune Diseases

China
Luminary Therapeutics

Not yet recruiting

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Non-Hodgkin Lymphoma | Multiple Myeloma in Relapse | Non-Hodgkin Lymphoma (NHL) | Non-Hodgkin Lymphoma, B-cell | Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | Multiple Myeloma in Remission | Non-Hodgkin Lymphoma Refractory/ Relapsed | Multiple Myeloma Refractory

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe